These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 29737910)
1. In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers. Patel NR; Piroyan A; Ganta S; Morse AB; Candiloro KM; Solon AL; Nack AH; Galati CA; Bora C; Maglaty MA; O'Brien SW; Litwin S; Davis B; Connolly DC; Coleman TP Cancer Biol Ther; 2018 Jul; 19(7):554-564. PubMed ID: 29737910 [TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Characterization of Folate-Targeted Platinum-Loaded Theranostic Nanoemulsions for Therapy and Imaging of Ovarian Cancer. Patel NR; Piroyan A; Nack AH; Galati CA; McHugh M; Orosz S; Keeler AW; O'Neal S; Zamboni WC; Davis B; Coleman TP Mol Pharm; 2016 Jun; 13(6):1996-2009. PubMed ID: 27170232 [TBL] [Abstract][Full Text] [Related]
3. Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer. Ganta S; Singh A; Rawal Y; Cacaccio J; Patel NR; Kulkarni P; Ferris CF; Amiji MM; Coleman TP Drug Deliv; 2016; 23(3):968-80. PubMed ID: 24901206 [TBL] [Abstract][Full Text] [Related]
4. Kazemi M; Emami J; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A; Mokhtari M Recent Pat Anticancer Drug Discov; 2020; 15(4):341-359. PubMed ID: 33023456 [TBL] [Abstract][Full Text] [Related]
5. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer. Li S; Li X; Ding J; Han L; Guo X Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163 [No Abstract] [Full Text] [Related]
6. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system. Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995 [TBL] [Abstract][Full Text] [Related]
8. Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy. Yadav S; Gupta S Artif Cells Nanomed Biotechnol; 2015 Apr; 43(2):93-102. PubMed ID: 24195582 [TBL] [Abstract][Full Text] [Related]
9. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy. Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783 [TBL] [Abstract][Full Text] [Related]
10. Theranostic Nanoparticles Loaded with Imaging Probes and Rubrocurcumin for Combined Cancer Therapy by Folate Receptor Targeting. Alberti D; Protti N; Franck M; Stefania R; Bortolussi S; Altieri S; Deagostino A; Aime S; Geninatti Crich S ChemMedChem; 2017 Apr; 12(7):502-509. PubMed ID: 28217982 [TBL] [Abstract][Full Text] [Related]
11. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells. Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445 [TBL] [Abstract][Full Text] [Related]
12. Folate Modified Long Circulating Nano-Emulsion as a Promising Approach for Improving the Efficiency of Chemotherapy Drugs in Cancer Treatment. Song B; Wu S; Li W; Chen D; Hu H Pharm Res; 2020 Nov; 37(12):242. PubMed ID: 33188481 [TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles. Jiang S; Gong X; Zhao X; Zu Y Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890 [TBL] [Abstract][Full Text] [Related]
14. Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616 [No Abstract] [Full Text] [Related]
15. Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy. Wang L; Li M; Zhang N Int J Nanomedicine; 2012; 7():3281-94. PubMed ID: 22802688 [TBL] [Abstract][Full Text] [Related]
16. AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging. Chauhan M; Sonali ; Shekhar S; Yadav B; Garg V; Dutt R; Mehata AK; Goswami P; Koch B; Muthu MS; Singh RP Biomater Adv; 2024 Jun; 160():213833. PubMed ID: 38564997 [TBL] [Abstract][Full Text] [Related]
17. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo. Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681 [TBL] [Abstract][Full Text] [Related]
18. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery. Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169 [TBL] [Abstract][Full Text] [Related]
19. Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer. Ganta S; Singh A; Patel NR; Cacaccio J; Rawal YH; Davis BJ; Amiji MM; Coleman TP Pharm Res; 2014 Sep; 31(9):2490-502. PubMed ID: 24643932 [TBL] [Abstract][Full Text] [Related]
20. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy. Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]